glp 1 and prediabetes GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1-based therapies for type 2
Description
Not approved for diagnostic, therapeutic, or medical applications
Pharma leaders reveal how blockbuster therapies are reshaping M&A priorities and portfolios.
Midis weight specialists understand the "why" behind menopausal body changes and find weight loss solutions, from lifestyle coaching to medications.
Read a full license here
